Literature DB >> 10828379

Changes in pupil reaction to light in Alzheimer's disease patients: a preliminary report.

F Fotiou1, K N Fountoulakis, M Tsolaki, A Goulas, A Palikaras.   

Abstract

The aim of this preliminary study was to compare the pupil reaction to light in Alzheimer's disease (AD) patients before and after treatment and in normal controls. Ten AD patients diagnosed according to DSM-IV and NINCDS-ADRDA criteria (five medication-free and five under anticholinesterase treatment) and five age- and gender-matched controls took part in the study. Drug-free patients and all control subjects were free of any medication for at least four weeks. An optical method was used to assess the pupil reaction to a single flash. Medication-free AD patients manifested shorter latency and lower amplitude of maximum response to light in comparison to controls. These findings are in agreement with the presence of a cholinergic deficit in AD patients. Pharmacological treatment with donepezil, which is an anticholinesterase agent partially improves this deficit. The results of this preliminary investigation suggest that dynamic pupillometry could be a useful adjunct to assist the diagnosis of early AD, and the differential diagnosis between different types of dementia. AD patients seem to manifest a specific pattern of pupil reaction to light, and some characteristics of this pattern are detectable even in patients receiving anticholinesterase medication. However, this is only a preliminary report and further research is mandatory.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828379     DOI: 10.1016/s0167-8760(00)00099-4

Source DB:  PubMed          Journal:  Int J Psychophysiol        ISSN: 0167-8760            Impact factor:   2.997


  23 in total

1.  Effects of azelnidipine and amlodipine on exercise-induced sympathoexcitation assessed by pupillometry in hypertensive patients.

Authors:  Yumi Koike; Tetsuya Kawabe; Kanami Nishihara; Naomi Iwane; Takuzo Hano
Journal:  Hypertens Res       Date:  2016-07-21       Impact factor: 3.872

2.  Pupillometry measures of autonomic nervous system regulation with advancing age in a healthy pediatric cohort.

Authors:  Molly Winston; Amy Zhou; Casey M Rand; Emma C Dunne; Justin J Warner; Lena J Volpe; Brooke A Pigneri; Drew Simon; Thomas Bielawiec; Samantha C Gordon; Sally F Vitez; Aaron Charnay; Stephen Joza; Kristen Kelly; Cia Panicker; Saajidha Rizvydeen; Grace Niewijk; Cara Coleman; Bradley J Scher; David W Reed; Sara M Hockney; Gigi Buniao; Tracey Stewart; Lynne Trojanowski; Cindy Brogadir; Michelle Price; Anna S Kenny; Allison Bradley; Nicholas J Volpe; Debra E Weese-Mayer
Journal:  Clin Auton Res       Date:  2019-09-25       Impact factor: 4.435

3.  The use of pupillometry in the assessment of cardiac autonomic function in elite different type trained athletes.

Authors:  Antonia Kaltsatou; Evangelia Kouidi; Dimitrios Fotiou; Pantazis Deligiannis
Journal:  Eur J Appl Physiol       Date:  2011-01-23       Impact factor: 3.078

Review 4.  Eye movements in Alzheimer's disease.

Authors:  Robert J Molitor; Philip C Ko; Brandon A Ally
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Machine learning for comprehensive prediction of high risk for Alzheimer's disease based on chromatic pupilloperimetry.

Authors:  Yael Lustig-Barzelay; Ifat Sher; Inbal Sharvit-Ginon; Yael Feldman; Michael Mrejen; Shada Dallasheh; Abigail Livny; Michal Schnaider Beeri; Aron Weller; Ramit Ravona-Springer; Ygal Rotenstreich
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

6.  Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers.

Authors:  Shaun M Frost; Yogesan Kanagasingam; Hamid R Sohrabi; Kevin Taddei; Randall Bateman; John Morris; Tammie Benzinger; Alison Goate; Colin L Masters; Ralph N Martins
Journal:  Curr Alzheimer Res       Date:  2013-10       Impact factor: 3.498

7.  Pupillary dilation responses as a midlife indicator of risk for Alzheimer's disease: association with Alzheimer's disease polygenic risk.

Authors:  William S Kremen; Matthew S Panizzon; Jeremy A Elman; Eric L Granholm; Ole A Andreassen; Anders M Dale; Nathan A Gillespie; Daniel E Gustavson; Mark W Logue; Michael J Lyons; Michael C Neale; Chandra A Reynolds; Nathan Whitsel; Carol E Franz
Journal:  Neurobiol Aging       Date:  2019-09-09       Impact factor: 4.673

Review 8.  Interconnection between brain and retinal neurodegenerations.

Authors:  Vishal Jindal
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

9.  Therapeutic approaches to age-associated neurocognitive disorders.

Authors:  R O'Hara; C Derouesné; K N Fountoulakis; J A Yesavage
Journal:  Dialogues Clin Neurosci       Date:  2001-09       Impact factor: 5.986

Review 10.  How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis?

Authors:  E Jones-Odeh; C J Hammond
Journal:  Eye (Lond)       Date:  2015-09-04       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.